A study to investigate the pharmacokinetics in children (aged 1 month to 17 years) with epilepsy, prescribed lacosamide. - Trial 2014-002629-36
Access comprehensive clinical trial information for 2014-002629-36 through Pure Global AI's free database. This phase not specified trial is sponsored by UCB Biosciences, Inc and is currently status unknown. The study focuses on Epilepsy.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
2014-002629-36
Trial Details
EU Clinical Trials Register • 2014-002629-36
A study to investigate the pharmacokinetics in children (aged 1 month to 17 years) with epilepsy, prescribed lacosamide.
Study Focus
Sponsor & Location
UCB Biosciences, Inc
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
- Area under the concentration time curve at steady state (AUCss) for Lacosamine
ICD-10 Classifications
Epilepsy
Epilepsy, unspecified
Other epilepsy
Status epilepticus
Other status epilepticus
Data Source
EU Clinical Trials Register
2014-002629-36
Non-Device Trial